Affordable Access

deepdyve-link
Publisher Website

Results of a randomized trial of chlorambucil versus fludarabine for patients with untreated Waldenström macroglobulinemia, marginal zone lymphoma, or lymphoplasmacytic lymphoma.

Authors
  • Leblond, Véronique
  • Johnson, Steve
  • Chevret, Sylvie
  • Copplestone, Adrian
  • Rule, Simon
  • Tournilhac, Olivier
  • Seymour, John Francis
  • Patmore, Russell D
  • Wright, David
  • Morel, Pierre
  • Dilhuydy, Marie-Sarah
  • Willoughby, Sara
  • Dartigeas, Caroline
  • Malphettes, Marion
  • Royer, Bruno
  • Ewings, Maeve
  • Pratt, Guy
  • Lejeune, Julie
  • Nguyen-Khac, Florence
  • Choquet, Sylvain
  • And 1 more
Type
Published Article
Journal
Journal of Clinical Oncology
Publisher
American Society of Clinical Oncology
Publication Date
Jan 20, 2013
Volume
31
Issue
3
Pages
301–307
Identifiers
DOI: 10.1200/JCO.2012.44.7920
PMID: 23233721
Source
Medline
License
Unknown

Abstract

In the complete intent-to-treat study population, fludarabine significantly improved PFS compared with chlorambucil, and in patients with WM, it improved OS.

Report this publication

Statistics

Seen <100 times